Determining the crystal structure of alkCDase3 elucidated the possibility of the structure-based discovery of small molecules to manipulate their activity for therapeutic interventions [212], providing an opportunity to modulate alkCDase3 activity to decrease pathogenesis in specific cancers. The gene discussed is ACER3; the disease is cancer.